SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-010967
Filing Date
2023-02-06
Accepted
2023-02-06 09:49:12
Documents
13
Period of Report
2023-02-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm235315d2_8k.htm   iXBRL 8-K 27261
2 EXHIBIT 99.1 tm235315d2_ex99-1.htm EX-99.1 9305
  Complete submission text file 0001104659-23-010967.txt   215148

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acgn-20230206.xsd EX-101.SCH 3042
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acgn-20230206_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acgn-20230206_pre.xml EX-101.PRE 22601
7 EXTRACTED XBRL INSTANCE DOCUMENT tm235315d2_8k_htm.xml XML 3598
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
Aceragen, Inc. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 23588893
SIC: 2836 Biological Products, (No Diagnostic Substances)